×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [asco annual meetingconclusions]
Randomized Comparison of Ibrutinib Versus Ofatumumab in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Results From the
218 views
Efficacy and Safety of Continued Zoledronic Acid every 4 Weeks versus every 12 Weeks in Women with Bone Metastases from Breast Cancer: Results of the OPTIMIZE-2
218 views
Presented By Halle Moore at 2014 ASCO Annual Meeting
28 views
Treatment outcome according to tumor RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized to FOLFIRI with/without
216 views
Slide 1
44 views
Presented By Amy Abernethy at 2014 ASCO Annual Meeting
58 views
Presented By Olivia Pagani at 2014 ASCO Annual Meeting
77 views
Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer Presented By Junzo Hamanishi
232 views
Presented By Gabriel Hortobagyi at 2014 ASCO Annual Meeting
60 views
Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting
22 views
Presented By Mario Sznol at 2014 ASCO Annual Meeting
67 views
Presented By Halle Moore at 2014 ASCO Annual Meeting
43 views
Next >